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Methamphetamine hydrochloride, colloquially referred to as “crystal meth,” is a potent psychoactive amphetamine derivate.
Methamphetamine produces stimulant effects in the user including increased energy and alertness as well as inducing
intense euphoric symptoms and suppressing appetite through its dopaminergic, serotonergic, and adrenergic actions. Use
of methamphetamine can adversely affect cardiovascular, neurological, and gastrointestinal physiology leading to significant
morbidity.Wepresent a rare case of paralytic ileus secondary tomethamphetamine abusewhich has only once before been described
in the literature.
1. Introduction
Methamphetamine hydrochloride, colloquially referred to
as “crystal meth,” is a potent psychoactive amphetamine
derivate. Its use produces stimulant effects in the individual
user; these include feelings of increased energy and alertness
in addition to intense euphoria and appetite suppression
[1]. The prevalence of methamphetamine use is lower in
the United Kingdom than it is in the United States with
a recent Home Office survey revealing 0.2% of 16–24 year
olds reporting methamphetamine use in 2014-15 [2]. Com-
paratively, in the United States, 0.9% of 18–25 year olds had
reported use of methamphetamine in 2014-15 [3]. Serious
neurologic, cardiovascular, and gastrointestinal harm has
previously been reported following methamphetamine use,
probably through the downstreameffects ofmonoamine neu-
rotransmitter release [1, 4]. We describe a rare case, hitherto
reported only once before in the English-written literature,
of methamphetamine-induced paralytic ileus and discuss the
possible underlying pathophysiological mechanisms.
2. Case Presentation
A forty-two-year-old gentleman presented to the emergency
department complaining of a one-day history of increasing
central abdominal pain and distension. He was nauseated
and had vomited watery-brown vomitus five times prior to
admission. His bowels had opened the day before but had
not opened on the day of admission nor had he passed flatus.
His past medical history included regular methamphetamine
use (approximately one-quarter ounce, equivalent to approx-
imately seven grams, every five days), previous intravenous
drug use, and asthma, forwhich he regularly used a combined
steroid and beta-agonist inhaler. He had had no previous
abdominal surgery. He volunteered that in the four days prior
to the onset of symptoms he had consumed two to three times
his usual amount of methamphetamine, which he swallowed
as an oral paste. Physical examination revealed he was mildly
dehydrated, with no pallor or icterus. His abdomen was
distended and tympanic with absent bowel sounds. There
were no signs of peritonism or herniae. Rectal examination
revealed a collapsed rectum with no masses. Vital signs
showed a tachycardia of 116 beats per minute, blood pressure
of 132/84mmHg, and temperature of 36.0∘C. Laboratory
studies revealed a white cell count of 14.0 × 109 cells/l (91%
neutrophils) and a C-reactive protein of 43mg/l. Renal and
liver function tests, and amylase, were normal and venous
gas analysis revealed a pH of 7.39, PaCO2 of 6.0 kPa, serum
bicarbonate of 27.2mmol/l, base excess of 2.2mmol/l, and
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Figure 1: Abdominal plain film radiography demonstrating multi-
ple dilated small bowel loops.
serum lactate of 0.9mmol/l. Dipstick urinalysis was negative
and plain film radiography of the chest was unremarkable.
Abdominal plain film radiography demonstrated multiple
dilated loops of small bowel (Figure 1). The patient was
admitted under the general surgical team with paralytic ileus
secondary to methamphetamine use, made “nil-by-mouth”
and treated with intravenous fluids and a nasogastric tube
for gastric decompression. The patient’s symptoms began to
improve within twenty-four hours of admission after which
the nasogastric tube was removed. By forty-eight hours he
returned to full oral diet and was discharged home with
outpatient drug liaison service follow-up. There had been
no recurrence of symptoms since discharge when he was
followed up two months later.
3. Discussion
Multiple harmful effects, secondary to the use of metham-
phetamine, on the neurological, cardiovascular, and gas-
trointestinal systems have been described in the literature.
Methamphetamine-induced cerebrovascular accident (both
ischaemic and haemorrhagic) [5], neurodegenerative dis-
orders [6], and dyskinesias [7] have been described and
cardiovascular complications include acute coronary syn-
drome [8] and aortic dissection [9]. These effects appear
to be related to the stimulated release of neurotransmitters
including dopamine, serotonin, and/or noradrenaline [1, 10],
with noradrenaline acting via alpha-1 receptors in arterial
vasculature to stimulate vasoconstriction and via beta-1
receptors to increase cardiac contractility and heart rate [11],
leading to hypertension and tachycardia, and promoting car-
diac ischaemia. More recently, a study has demonstrated how
methamphetamine directly stimulates the release of endothe-
lin, a potent vasoconstrictor, in mouse arteriole suggest-
ing an additional mechanism in which methamphetamine
induces arterial vasoconstriction [12]. With this in mind,
methamphetamine-induced ischaemic colitis/infarction has
also been described several times before [13, 14], the mech-
anism of which may also lie in noradrenergic/endothelin-
mediated mesenteric arterial vasoconstriction. Carlson et al.
[15] have described a single case of paralytic ileus secondary
to methamphetamine. Similarly to the case described in our
report the patient presentedwith a short history of abdominal
pain, tachycardic, and with abdominal signs consistent with
ileus. Plain film radiography in both cases demonstrated
multiple dilated bowel loops. Like the patient described
in our report, there were no signs of intestinal ischaemia
(given the normal venous lactate level). In contrast, the
patient described in our report presented with multiple
episodes of vomiting and so a decision was made to insert
a nasogastric tube to provide gastric decompression and
symptomatic relief. The onset of symptoms also clearly
coincided with a preceding binge of two to three times
the quantity of methamphetamine usually ingested by the
patient. With no other obvious aetiology for the ileus, we
propose that the cause of the ileus was as a result of the
ingestion of a higher-than-usual dose of methamphetamine.
Separate to the vascular effects of the monoamine neuro-
transmitters, there appear to be direct effects of dopamine
and noradrenaline on the function of the gastrointestinal
tract. Studies implicate dopamine in intestinal motility [16],
with one study demonstrating how dopamine, acting at
the D1 receptor, causes concentration-dependent reduction
in mouse ileum muscle tone and markedly reduces small
bowel contractility [17]. Separately, noradrenaline acting on
intestinal smooth muscle has been shown to reduce motility
[11]. Whilst the exact mechanism for paralytic ileus in the
presented case is uncertain, in the absence of evidence of
mesenteric ischaemia and other precipitants of ileus, the
authors propose that the underlying mechanism for the
presentation may involve direct, nonvascular dopaminergic
and/or noradrenergic effects on intestinal smooth muscle,
secondary to methamphetamine administration, leading to
the symptoms and signs of ileus.
The case described is only one of two documented cases
of ileus secondary to methamphetamine abuse but reflects a
growing trend in recent years of more complications being
attributed to the potent stimulant.Whilst these complications
are rare, serious sequelae can occur in multiple systems
following methamphetamine use, leading to significant mor-
bidity. It is therefore important for the clinician to understand
the possible pathophysiological effects of the drug and to
consider this as a differential diagnosis in a user of metham-
phetamine who presents acutely with abdominal symptoms.
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